Low prevalence of drug resistant HIV-1 in patients newly diagnosed with early stage of HIV infection in Korea

Chang Oh Kim, Bum Sik Chin, Sang Hoon Han, Han Sung Lee, Su Jin Jeong, Hee Kyung Choi, JunYong Choi, Young Goo Song, Joo Shil Lee, June Myung Kim

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

There is a concern that the widespread use of antiretroviral drugs to treat HIV infections may result in the increased transmission of of a drug-resistant virus. Drug resistance testing before initiating treatment among newly diagnosed HIV patients is helpful in the design of initial regimens. Although HIV infected patients have been increasing in Korea, the transmission rate of drug-resistant HIV is unknown. The aim of this study was to determine the prevalence of antiretroviral drug resistance-associated mutations in patients newly diagnosed as early stage of HIV infection in Korea. We defined patients with early HIV infections as those with confirmed diagnoses who had an indeterminate Western blot. We performed genotypic resistance testing in 66 HIV-1 subjects at an early HIV infection stage who were identified between March 2002 and June 2005. Two of the 66 subjects with early HIV infections showed major mutations associated with resistance. Major mutations by themselves reduce susceptibility to one or more drugs and occur commonly during virological failure. Minor mutations have little or no effect on susceptibility and occur only after other drug-resistance mutations. The resistant mutation of reverse-transcriptase gene was found at E44D, and the major resistant mutation of protease gene was found at M46L. Minor protease resistance mutations were seen in 52 cases. Genetic subtype analysis revealed that all subjects were infected with HIV-1 subtype B. In conclusion, the prevalence of drug-resistant HIV-1 in patients newly diagnosed with HIV in its early infection stage is not high in Korea.

Original languageEnglish
Pages (from-to)259-265
Number of pages7
JournalTohoku Journal of Experimental Medicine
Volume216
Issue number3
DOIs
Publication statusPublished - 2008 Dec 1

Fingerprint

Korea
HIV Infections
HIV-1
Mutation
Pharmaceutical Preparations
Drug Resistance
HIV
Peptide Hydrolases
Genes
RNA-Directed DNA Polymerase
Testing
Viruses
Western Blotting
Infection

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Kim, Chang Oh ; Chin, Bum Sik ; Han, Sang Hoon ; Lee, Han Sung ; Jeong, Su Jin ; Choi, Hee Kyung ; Choi, JunYong ; Song, Young Goo ; Lee, Joo Shil ; Kim, June Myung. / Low prevalence of drug resistant HIV-1 in patients newly diagnosed with early stage of HIV infection in Korea. In: Tohoku Journal of Experimental Medicine. 2008 ; Vol. 216, No. 3. pp. 259-265.
@article{07af7049d2dc4ab0a654ae22eb63b9f2,
title = "Low prevalence of drug resistant HIV-1 in patients newly diagnosed with early stage of HIV infection in Korea",
abstract = "There is a concern that the widespread use of antiretroviral drugs to treat HIV infections may result in the increased transmission of of a drug-resistant virus. Drug resistance testing before initiating treatment among newly diagnosed HIV patients is helpful in the design of initial regimens. Although HIV infected patients have been increasing in Korea, the transmission rate of drug-resistant HIV is unknown. The aim of this study was to determine the prevalence of antiretroviral drug resistance-associated mutations in patients newly diagnosed as early stage of HIV infection in Korea. We defined patients with early HIV infections as those with confirmed diagnoses who had an indeterminate Western blot. We performed genotypic resistance testing in 66 HIV-1 subjects at an early HIV infection stage who were identified between March 2002 and June 2005. Two of the 66 subjects with early HIV infections showed major mutations associated with resistance. Major mutations by themselves reduce susceptibility to one or more drugs and occur commonly during virological failure. Minor mutations have little or no effect on susceptibility and occur only after other drug-resistance mutations. The resistant mutation of reverse-transcriptase gene was found at E44D, and the major resistant mutation of protease gene was found at M46L. Minor protease resistance mutations were seen in 52 cases. Genetic subtype analysis revealed that all subjects were infected with HIV-1 subtype B. In conclusion, the prevalence of drug-resistant HIV-1 in patients newly diagnosed with HIV in its early infection stage is not high in Korea.",
author = "Kim, {Chang Oh} and Chin, {Bum Sik} and Han, {Sang Hoon} and Lee, {Han Sung} and Jeong, {Su Jin} and Choi, {Hee Kyung} and JunYong Choi and Song, {Young Goo} and Lee, {Joo Shil} and Kim, {June Myung}",
year = "2008",
month = "12",
day = "1",
doi = "10.1620/tjem.216.259",
language = "English",
volume = "216",
pages = "259--265",
journal = "Tohoku Journal of Experimental Medicine",
issn = "0040-8727",
publisher = "Tohoku University Medical Press",
number = "3",

}

Low prevalence of drug resistant HIV-1 in patients newly diagnosed with early stage of HIV infection in Korea. / Kim, Chang Oh; Chin, Bum Sik; Han, Sang Hoon; Lee, Han Sung; Jeong, Su Jin; Choi, Hee Kyung; Choi, JunYong; Song, Young Goo; Lee, Joo Shil; Kim, June Myung.

In: Tohoku Journal of Experimental Medicine, Vol. 216, No. 3, 01.12.2008, p. 259-265.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Low prevalence of drug resistant HIV-1 in patients newly diagnosed with early stage of HIV infection in Korea

AU - Kim, Chang Oh

AU - Chin, Bum Sik

AU - Han, Sang Hoon

AU - Lee, Han Sung

AU - Jeong, Su Jin

AU - Choi, Hee Kyung

AU - Choi, JunYong

AU - Song, Young Goo

AU - Lee, Joo Shil

AU - Kim, June Myung

PY - 2008/12/1

Y1 - 2008/12/1

N2 - There is a concern that the widespread use of antiretroviral drugs to treat HIV infections may result in the increased transmission of of a drug-resistant virus. Drug resistance testing before initiating treatment among newly diagnosed HIV patients is helpful in the design of initial regimens. Although HIV infected patients have been increasing in Korea, the transmission rate of drug-resistant HIV is unknown. The aim of this study was to determine the prevalence of antiretroviral drug resistance-associated mutations in patients newly diagnosed as early stage of HIV infection in Korea. We defined patients with early HIV infections as those with confirmed diagnoses who had an indeterminate Western blot. We performed genotypic resistance testing in 66 HIV-1 subjects at an early HIV infection stage who were identified between March 2002 and June 2005. Two of the 66 subjects with early HIV infections showed major mutations associated with resistance. Major mutations by themselves reduce susceptibility to one or more drugs and occur commonly during virological failure. Minor mutations have little or no effect on susceptibility and occur only after other drug-resistance mutations. The resistant mutation of reverse-transcriptase gene was found at E44D, and the major resistant mutation of protease gene was found at M46L. Minor protease resistance mutations were seen in 52 cases. Genetic subtype analysis revealed that all subjects were infected with HIV-1 subtype B. In conclusion, the prevalence of drug-resistant HIV-1 in patients newly diagnosed with HIV in its early infection stage is not high in Korea.

AB - There is a concern that the widespread use of antiretroviral drugs to treat HIV infections may result in the increased transmission of of a drug-resistant virus. Drug resistance testing before initiating treatment among newly diagnosed HIV patients is helpful in the design of initial regimens. Although HIV infected patients have been increasing in Korea, the transmission rate of drug-resistant HIV is unknown. The aim of this study was to determine the prevalence of antiretroviral drug resistance-associated mutations in patients newly diagnosed as early stage of HIV infection in Korea. We defined patients with early HIV infections as those with confirmed diagnoses who had an indeterminate Western blot. We performed genotypic resistance testing in 66 HIV-1 subjects at an early HIV infection stage who were identified between March 2002 and June 2005. Two of the 66 subjects with early HIV infections showed major mutations associated with resistance. Major mutations by themselves reduce susceptibility to one or more drugs and occur commonly during virological failure. Minor mutations have little or no effect on susceptibility and occur only after other drug-resistance mutations. The resistant mutation of reverse-transcriptase gene was found at E44D, and the major resistant mutation of protease gene was found at M46L. Minor protease resistance mutations were seen in 52 cases. Genetic subtype analysis revealed that all subjects were infected with HIV-1 subtype B. In conclusion, the prevalence of drug-resistant HIV-1 in patients newly diagnosed with HIV in its early infection stage is not high in Korea.

UR - http://www.scopus.com/inward/record.url?scp=59849122930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59849122930&partnerID=8YFLogxK

U2 - 10.1620/tjem.216.259

DO - 10.1620/tjem.216.259

M3 - Article

C2 - 18987460

AN - SCOPUS:59849122930

VL - 216

SP - 259

EP - 265

JO - Tohoku Journal of Experimental Medicine

JF - Tohoku Journal of Experimental Medicine

SN - 0040-8727

IS - 3

ER -